MedTrace Logo

Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation

NCT02149732 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2016-04-20

No results posted yet for this study

Summary

To investigate the effect of ocular surface reconstruction and assess the safety in cultivated oral mucosal epithelial cell sheet transplantation (COMET) regarding patients with cicatricial change of ocular surface.

Conditions

  • Limbal Stem Cell Deficiency
  • Stevens-johnson Syndrome
  • Ocular Cicatricial Pemphigoid
  • Chemical Burn

Interventions

BIOLOGICAL

cultivated oral mucosal epithelial sheet transplantation

Autologous cultivated oral mucosal epithelial cell sheet transplantation using oral mucosal adult stem cells in the patients with intractable corneal limbal deficiency

Sponsors & Collaborators

  • Ministry of Health & Welfare, Korea

    collaborator OTHER_GOV

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Mee Kum Kim, MD, PhD · Department of Ophthalmology, Seoul National University College of Medicine

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149732 on ClinicalTrials.gov